Navigation Links
Salt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery
Date:5/5/2009

Aesthetic Society elects top officers at 2009 annual meeting in Las Vegas, NV.

New York, NY (Vocus) May 5, 2009 -- Utah plastic surgeon Renato Saltz, MD, is the new President of the American Society for Aesthetic Plastic Surgery (ASAPS). The Aesthetic Society, with nearly 2,400 members, is the leading national organization of board-certified plastic surgeons specializing in cosmetic surgery of the face and body. The election of new officers was held on May 5, during the ASAPS 2009 Annual Meeting in Las Vegas, NV which was attended by plastic surgeons from around the world.

Dr. Saltz is a native of Brazil. He lives and practices in Salt Lake City and Park City, UT. He has been an Aesthetic Society Member since 1995. He is in private practice in Salt Lake City, UT and is the Former Associate Professor of Plastic Surgery, University of Utah. Dr. Saltz is the former Chair of the Symposium and Candidate Liaison Committees, Residents' Forum, and the International Symposium and serves on the Aesthetic Surgery Journal Task Force. He is a Co-Chair of the Cosmetic Medicine Task Force and a Former Clinical Editor of the Aesthetic Surgery Journal. He is the Education Council Chair and Immediate Past-General Secretary of the International Society of Aesthetic Plastic Surgery (ISAPS). Dr. Saltz has been a visiting professor at 13 academic centers in the United States and Abroad and has given over 350 presentations nationally and internationally. He has published over 100 papers, 31 chapters and edited 6 books in Plastic & Reconstructive Surgery. Dr. Saltz is also the Founder and President of the Image Reborn Foundation of Utah, a retreat center for women recovering from breast cancer, now in its 10th year.

Dr. Saltz has been in practice for 19 years. He received his medical degree from Universidade Federal Rio Grande do Sul School of Medicine in Brazil and served his ge
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. First-Ever Standardized Scales to Measure the Skins Aging Process Are Introduced at the American Society for Aesthetic Plastic Surgerys Annual Meeting
2. Growth of Plastic Surgery & Botox Grannies in UK
3. Beverly Hills Cosmetic Plastic Surgeon Andrew T. Cohen, MD Helping New Moms Restore their Bodies with a Mommy Makeover
4. Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy
5. U.S. Plastic Surgeons Get Green Light for New Era of Fat Transfer Procedures.
6. Scottsdale, Arizona Cosmetic Plastic Surgeon Reaches Out to Patients with State-of-the-Art New Website
7. New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure
8. Revolutionary Breakthrough in Lip Augmentation: Valencia Plastic Surgeon offers Permanent Lip Implants as Injectible Alternative
9. Plastic Surgeon Allan Parungao, MD, FACS, Announces Clinical Trial of Juvderm Technique to Treat Root Cause of Midface Sagging, without Surgery
10. Orange County Plastic Surgeon Warns: When It Comes To The Face And Body, The Best Deal Could Cost More
11. Recession cuts many, not all plastic surgery procedures
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Salt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery
Salt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery
Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6